SJ Pocock

1.9k total citations · 1 hit paper
16 papers, 1.0k citations indexed

About

SJ Pocock is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, SJ Pocock has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in SJ Pocock's work include Diabetes Treatment and Management (4 papers), Heart Failure Treatment and Management (3 papers) and Cardiovascular Function and Risk Factors (3 papers). SJ Pocock is often cited by papers focused on Diabetes Treatment and Management (4 papers), Heart Failure Treatment and Management (3 papers) and Cardiovascular Function and Risk Factors (3 papers). SJ Pocock collaborates with scholars based in United Kingdom, United States and France. SJ Pocock's co-authors include Cono Ariti, Dee Dee Wang, Timothy Collier, John J.V. McMurray, Karl Swedberg, Scott D. Solomon, Salim Yusuf, Mary Walker, Stefan D. Anker and Joanna Dobson and has published in prestigious journals such as European Heart Journal, Diabetologia and International Journal of Obesity.

In The Last Decade

SJ Pocock

16 papers receiving 981 citations

Hit Papers

The win ratio: a new approach to the analysis of composit... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SJ Pocock United Kingdom 11 455 217 199 139 138 16 1.0k
Annemarie M.J. Wassink Netherlands 14 294 0.6× 187 0.9× 31 0.2× 74 0.5× 171 1.2× 18 686
P. Hougaard Denmark 6 192 0.4× 348 1.6× 46 0.2× 140 1.0× 193 1.4× 10 818
Joe Coresh United States 14 334 0.7× 118 0.5× 36 0.2× 57 0.4× 160 1.2× 21 1.2k
Thomas A. Murray United States 14 209 0.5× 63 0.3× 169 0.8× 39 0.3× 435 3.2× 48 1.4k
W S A Smellie United Kingdom 16 138 0.3× 110 0.5× 31 0.2× 301 2.2× 90 0.7× 46 851
Steadman S. Sankey United States 13 210 0.5× 151 0.7× 20 0.1× 63 0.5× 133 1.0× 15 840
Mugdha Gokhale United States 14 52 0.1× 117 0.5× 79 0.4× 101 0.7× 92 0.7× 31 603
F Sestier Canada 14 785 1.7× 176 0.8× 13 0.1× 80 0.6× 290 2.1× 33 1.3k
C. Droz‐Perroteau France 18 148 0.3× 60 0.3× 34 0.2× 187 1.3× 60 0.4× 68 872
Christine G. Kohn United States 17 335 0.7× 153 0.7× 14 0.1× 38 0.3× 156 1.1× 46 954

Countries citing papers authored by SJ Pocock

Since Specialization
Citations

This map shows the geographic impact of SJ Pocock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Pocock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Pocock more than expected).

Fields of papers citing papers by SJ Pocock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SJ Pocock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Pocock. The network helps show where SJ Pocock may publish in the future.

Co-authorship network of co-authors of SJ Pocock

This figure shows the co-authorship network connecting the top 25 collaborators of SJ Pocock. A scholar is included among the top collaborators of SJ Pocock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SJ Pocock. SJ Pocock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Butler, Javed, Nikolaus Marx, Piotr Ponikowski, et al.. (2021). Effect of Empagliflozin on Cardiovascular and Kidney Outcomes in Patients with Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial. Diabetologie und Stoffwechsel. 5 indexed citations
3.
Padwal, Raj, Finlay A. McAlister, John J.V. McMurray, et al.. (2013). The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. International Journal of Obesity. 38(8). 1110–1114. 162 indexed citations
4.
Zannad, Faı̈ez, Wendy Gattis Stough, SJ Pocock, et al.. (2012). Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?. European Heart Journal. 33(9). 1049–1057. 11 indexed citations
5.
Pocock, SJ, Cono Ariti, Timothy Collier, & Dee Dee Wang. (2011). The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. European Heart Journal. 33(2). 176–182. 412 indexed citations breakdown →
6.
Poppe, Katrina, Colin Berry, Joanna Dobson, et al.. (2010). Characteristics and survival of heart failure patients in whom left ventricular ejection fraction is not assessed: analysis from a large-scale individual patient meta-analysis (MAGGIC). LSHTM Research Online (London School of Hygiene and Tropical Medicine). 1 indexed citations
7.
Pocock, SJ, John J.V. McMurray, Joanna Dobson, et al.. (2008). Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. European Heart Journal. 29(21). 2641–2650. 153 indexed citations
8.
Home, P. D., SJ Pocock, Henning Beck‐Nielsen, et al.. (2005). Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia. 48(9). 1726–1735. 115 indexed citations
9.
Pocock, SJ, et al.. (2000). Income inequality and mortality: importance to health of individual income, psychosocial environment, or material conditions. 2 indexed citations
10.
Lubsen, Jacobus, et al.. (1998). Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.. PubMed. 19 Suppl I. I20–32. 22 indexed citations
11.
Pocock, SJ, A. G. Shaper, Andrew Phillips, & Mary Walker. (1988). Prediction of men at high risk of heart attack and its relevance to pilots. European Heart Journal. 9(suppl G). 25–30. 23 indexed citations
12.
Phillips, A N, A. G. Shaper, SJ Pocock, & Mary Walker. (1988). Parental death from heart disease and the risk of heart attack. European Heart Journal. 9(3). 243–251. 29 indexed citations
13.
Pocock, SJ, et al.. (1987). A scoring system to identify men at high risk of a heart attack.. PubMed. 19(2). 37–9. 29 indexed citations
14.
Shaper, A G, AN Phillips, SJ Pocock, & Morgan Walker. (1987). ALCOHOL AND ISCHEMIC-HEART-DISEASE IN MIDDLE-AGED BRITISH MEN - REPLY. 6 indexed citations
15.
Shaper, A. G., Andrew Phillips, SJ Pocock, & Mary Walker. (1987). 7 Systolic and Diastolic Blood Pressures in the Prediction of Heart Attacks and Stroke. Journal of Hypertension. 5(6). 764–764. 1 indexed citations
16.
Vetter, Norman, SJ Pocock, & Desmond G. Julian. (1979). Measuring the effect of a mobile coronary care unit upon the community.. Heart. 41(4). 418–425. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026